Genmab A Stock Ownership - Who owns Genmab A?

Open Broker Account

Insider buying vs selling

Have Genmab A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GMAB insiders and whales buy or sell their stock.

GMAB Shareholders

What type of owners hold Genmab A stock?
Alliancebernstein LP8.78%5,779,489$256.09MInstitution
Blackrock Inc8.01%5,269,859$233.51MInstitution
Capital International Investors7.36%4,846,296$214.74MInstitution
Wellington Management Group LLP5.11%3,361,711$148.96MInstitution
Macquarie Group Ltd4.95%3,258,316$144.38MInstitution
1832 Asset Management LP3.48%2,288,246$101.39MInstitution
Arrowstreet Capital Limited Partnership2.26%1,485,526$65.82MInstitution
First Trust Advisors LP1.96%1,291,500$57.23MInstitution
Artisan Partners Limited Partnership1.51%991,261$43.92MInstitution
Renaissance Technologies LLC1.39%916,400$40.61MInstitution

1 of 3

GMAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALNY82.69%17.31%Net SellingNet Buying
RPRX48.15%16.22%Net SellingNet Selling
SGEN45.28%54.72%Net SellingNet Selling

Genmab A Stock Ownership FAQ

Who owns Genmab A?

Genmab A (NASDAQ: GMAB) is owned by 67.38% institutional shareholders, 0.00% Genmab A insiders, and 32.62% retail investors. Alliancebernstein LP is the largest individual Genmab A shareholder, owning 5.78M shares representing 8.78% of the company. Alliancebernstein LP's Genmab A shares are currently valued at $268.92M.

If you're new to stock investing, here's how to buy Genmab A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.